These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31545922)
1. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. Dong TS; Chang HH; Hauer M; Lagishetty V; Katzka W; Rozengurt E; Jacobs JP; Eibl G Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G763-G772. PubMed ID: 31545922 [TBL] [Abstract][Full Text] [Related]
2. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model. Chang HH; Moro A; Chou CEN; Dawson DW; French S; Schmidt AI; Sinnett-Smith J; Hao F; Hines OJ; Eibl G; Rozengurt E Sci Rep; 2018 Apr; 8(1):5899. PubMed ID: 29651002 [TBL] [Abstract][Full Text] [Related]
3. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras. Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766 [No Abstract] [Full Text] [Related]
4. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. He P; Yang JW; Yang VW; Bialkowska AB Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441 [TBL] [Abstract][Full Text] [Related]
5. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823 [TBL] [Abstract][Full Text] [Related]
6. Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes. Silamiķele L; Saksis R; Silamiķelis I; Kotoviča PP; Brīvība M; Kalniņa I; Kalniņa Z; Fridmanis D; Kloviņš J Gut Microbes; 2023; 15(1):2188663. PubMed ID: 36927522 [TBL] [Abstract][Full Text] [Related]
7. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes. Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284 [TBL] [Abstract][Full Text] [Related]
8. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice. Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056 [TBL] [Abstract][Full Text] [Related]
9. Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model. Cheng M; Jia X; Ren L; Chen S; Wang W; Wang J; Cong B Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000356 [TBL] [Abstract][Full Text] [Related]
10. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Chang HH; Moro A; Takakura K; Su HY; Mo A; Nakanishi M; Waldron RT; French SW; Dawson DW; Hines OJ; Li G; Go VLW; Sinnett-Smith J; Pandol SJ; Lugea A; Gukovskaya AS; Duff MO; Rosenberg DW; Rozengurt E; Eibl G PLoS One; 2017; 12(9):e0184455. PubMed ID: 28886117 [TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model. Mohammed A; Janakiram NB; Li Q; Madka V; Ely M; Lightfoot S; Crawford H; Steele VE; Rao CV Cancer Prev Res (Phila); 2010 Nov; 3(11):1417-26. PubMed ID: 21084261 [TBL] [Abstract][Full Text] [Related]
12. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106 [TBL] [Abstract][Full Text] [Related]
13. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Teper Y; Ye L; Waldron RT; Lugea A; Sun X; Sinnett-Smith J; Hines OJ; Pandol SJ; Rozengurt E; Eibl G Sci Rep; 2023 Sep; 13(1):16144. PubMed ID: 37752238 [TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury. Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Takahashi R; Macchini M; Sunagawa M; Jiang Z; Tanaka T; Valenti G; Renz BW; White RA; Hayakawa Y; Westphalen CB; Tailor Y; Iuga AC; Gonda TA; Genkinger J; Olive KP; Wang TC Gut; 2021 Feb; 70(2):330-341. PubMed ID: 32393543 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma. Pfisterer N; Ammer-Herrmenau C; Antweiler K; Küffer S; Ellenrieder V; Neesse A Pancreatology; 2023 Sep; 23(6):663-673. PubMed ID: 37541802 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001 [TBL] [Abstract][Full Text] [Related]
18. Diet Supplementation with Fish-Derived Extracts Suppresses Diabetes and Modulates Intestinal Microbiome in a Murine Model of Diet-Induced Obesity. Axarlis K; Daskalaki MG; Michailidou S; Androulaki N; Tsoureki A; Mouchtaropoulou E; Kolliniati O; Lapi I; Dermitzaki E; Venihaki M; Kousoulaki K; Argiriou A; Marsni ZE; Tsatsanis C Mar Drugs; 2021 May; 19(5):. PubMed ID: 34064922 [TBL] [Abstract][Full Text] [Related]
19. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
20. The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine. Chen SM; Chieng WW; Huang SW; Hsu LJ; Jan MS Sci Rep; 2020 Nov; 10(1):20319. PubMed ID: 33230218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]